Biotechnology Companies Developing Innovative CAR-T cells Therapy

Aleta BioTherapeutics
Allogene Therapeutics
Anixa Biosciences, Inc.
Atara Biotherapeutics
Autolus Therapeutics, plc
Bellicum Pharmaceuticals, Inc.
BioNTech
bluebird bio
Carina Biotech
CARsgen Therapeutics
Celgene Corporation
Cellectis
Celularity, Inc.
Celyad Oncology
CRISPR Therapeutics
Cytovia Therapeutics
DiaCarta, Inc.
Eureka Therapeutics, Inc.
EXUMA Biotech Corp.
Fate Therapeutics, Inc.
Formula Pharmaceuticals, Inc.
Gilead Sciences, Inc.
Gracell Biotechnologies
iCell Gene Therapeutics
Janssen Biotech, Inc.
Juno Therapeutics
JW Therapeutics, Co., Ltd.
Relmacabtagene autoleucel (Relma-cel)
Kite Pharma, Inc.
Minerva Biotechnologies Corporation
Mustang Bio, Inc.
Nanjing Legend Biotechnology Co., Ltd.
Noile-Immune Biotech
Novartis International, AG
Oxford Biomedica plc
 PeproMene Bio, Inc.
Poseida Therapeutics, Inc.
PiggyBac DNA Modification System
Autologous & Allogeneic Programs
Precigen, Inc.
Precision Biosciences
Prescient Therapeutics
OmniCAR Technology
ProMab Biotechnologies, Inc.
Protheragen
Sorrento Therapeutics, Inc.
TC Biopharm
T-CURX
 Tessa Therapeutics, Pvt. Ltd.
CD30 CAR-T Cells
Allogeneic CD30-CAR EBVSTs
Tmunity Therapeutics, Inc.
Wugen
Xyphos Biosciences, Inc.
Ziopharm Oncology, Inc.

Pages You May Like